137 related articles for article (PubMed ID: 10522499)
1. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
Papadimitrakopoulou VA; Clayman GL; Shin DM; Myers JN; Gillenwater AM; Goepfert H; El-Naggar AK; Lewin JS; Lippman SM; Hong WK
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1083-9. PubMed ID: 10522499
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer.
Izzo JG; Papadimitrakopoulou VA; Liu DD; den Hollander PL; Babenko IM; Keck J; El-Naggar AK; Shin DM; Lee JJ; Hong WK; Hittelman WN
J Natl Cancer Inst; 2003 Feb; 95(3):198-205. PubMed ID: 12569141
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity.
Dimery IW; Hong WK; Lee JJ; Guillory-Perez C; Pham F; Fritsche HA; Lippman SM
Ann Oncol; 1997 Jan; 8(1):85-9. PubMed ID: 9093712
[TBL] [Abstract][Full Text] [Related]
4. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
Mao L; El-Naggar AK; Papadimitrakopoulou V; Shin DM; Shin HC; Fan Y; Zhou X; Clayman G; Lee JJ; Lee JS; Hittelman WN; Lippman SM; Hong WK
J Natl Cancer Inst; 1998 Oct; 90(20):1545-51. PubMed ID: 9790547
[TBL] [Abstract][Full Text] [Related]
5. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
Papadimitrakopoulou VA; Liu DD; Mao L; Shin DM; El-Naggar A; Ibarguen H; Lee JJ; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1605-10. PubMed ID: 12496051
[TBL] [Abstract][Full Text] [Related]
6. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.
Benner SE; Winn RJ; Lippman SM; Poland J; Hansen KS; Luna MA; Hong WK
J Natl Cancer Inst; 1993 Jan; 85(1):44-7. PubMed ID: 8416256
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 and cancer development in laryngeal premalignancy patients.
Papadimitrakopoulou V; Izzo JG; Liu DD; Myers J; Ceron TL; Lewin J; William WN; Atwell A; Lee JJ; Gillenwater A; El-Naggar A; Wu X; Lippman SM; Hittelman WN; Hong WK
Cancer Prev Res (Phila); 2009 Jan; 2(1):14-21. PubMed ID: 19139013
[TBL] [Abstract][Full Text] [Related]
8. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
9. p53 and retinoid chemoprevention of oral carcinogenesis.
Lippman SM; Shin DM; Lee JJ; Batsakis JG; Lotan R; Tainsky MA; Hittelman WN; Hong WK
Cancer Res; 1995 Jan; 55(1):16-9. PubMed ID: 7805028
[TBL] [Abstract][Full Text] [Related]
10. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.
Lotan R; Xu XC; Lippman SM; Ro JY; Lee JS; Lee JJ; Hong WK
N Engl J Med; 1995 May; 332(21):1405-10. PubMed ID: 7723796
[TBL] [Abstract][Full Text] [Related]
11. Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.
Seixas-Silva JA; Richards T; Khuri FR; Wieand HS; Kim E; Murphy B; Francisco M; Hong WK; Shin DM
Arch Otolaryngol Head Neck Surg; 2005 Apr; 131(4):304-7. PubMed ID: 15837897
[TBL] [Abstract][Full Text] [Related]
12. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.
Shin DM; Mao L; Papadimitrakopoulou VM; Clayman G; El-Naggar A; Shin HJ; Lee JJ; Lee JS; Gillenwater A; Myers J; Lippman SM; Hittelman WN; Hong WK
J Natl Cancer Inst; 2000 Jan; 92(1):69-73. PubMed ID: 10620636
[No Abstract] [Full Text] [Related]
13. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of oral cancer in leukoplakia patients: A systematic review and meta-analysis.
Xie A; Liu J
J Pak Med Assoc; 2017 Sep; 67(9):1415-1419. PubMed ID: 28924285
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of oral squamous cell carcinomas.
Scheer M; Kuebler AC; Zöller JE
Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid.
Beenken SW; Sellers MT; Huang P; Peters G; Krontiras H; Dixon P; Stockard C; Listinsky C; Grizzle WE
Head Neck; 1999 Sep; 21(6):566-73. PubMed ID: 10449674
[TBL] [Abstract][Full Text] [Related]
17. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
Motzer RJ; Murphy BA; Bacik J; Schwartz LH; Nanus DM; Mariani T; Loehrer P; Wilding G; Fairclough DL; Cella D; Mazumdar M
J Clin Oncol; 2000 Aug; 18(16):2972-80. PubMed ID: 10944130
[TBL] [Abstract][Full Text] [Related]
18. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Papadimitrakopoulou VA; Lee JJ; William WN; Martin JW; Thomas M; Kim ES; Khuri FR; Shin DM; Feng L; Hong WK; Lippman SM
J Clin Oncol; 2009 Feb; 27(4):599-604. PubMed ID: 19075276
[TBL] [Abstract][Full Text] [Related]
20. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy.
Benner SE; Lippman SM; Wargovich MJ; Lee JJ; Velasco M; Martin JW; Toth BB; Hong WK
Int J Cancer; 1994 Nov; 59(4):457-9. PubMed ID: 7960211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
